OBJECTIVE: We sought to provide an updated estimate of the current prevalence and recent trends (over the past two decades) in pediatric-onset conditions among a nationally-representative sample of youth to identify opportunities for prevention and intervention. METHODS: We performed a secondary data analysis of nationally-representative data on 236,412 participants (ages 5-25 years) from the 1999 to 2018 National Health Interview Survey. Chronic conditions (CCs) and functional limitations (FLs) were self-reported by the participant or a qualified proxy-respondent. We employed multivariate linear probability models to estimate annual average increase in CC/FL prevalence and differences in prevalence across sociodemographic characteristics. RESULTS: The prevalence of children (5-17 years) with a CC/FL has risen from 22.57% in 1999/2000 to 30.21% in 2017/2018 - an adjusted annual increase of 0.24% points per year (P<.0001) or about 130,000 additional children per year. The prevalence of young adults (18-25 years) with a CC/FL has risen similarly (adjusted annual increase of 0.33% points per year, P<.0001). Asthma and mental/behavioral health conditions were some of the leading CC and FL (respectively) contributors to this increase for both age groups. We estimate that approximately 1.2 million youth with a CC or FL currently turn 18 each year. CONCLUSIONS: The US is currently seeing an unprecedented number of youth with pediatric-onset conditions. It is incumbent for the US health system to seek ways to treat these patients in pediatric settings and eventually matriculate them into adult care.
No takes yet. Share an insight, caveat, or question.
Wisk et al. (2025) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: